ATE326217T1 - Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin - Google Patents

Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin

Info

Publication number
ATE326217T1
ATE326217T1 AT02702462T AT02702462T ATE326217T1 AT E326217 T1 ATE326217 T1 AT E326217T1 AT 02702462 T AT02702462 T AT 02702462T AT 02702462 T AT02702462 T AT 02702462T AT E326217 T1 ATE326217 T1 AT E326217T1
Authority
AT
Austria
Prior art keywords
producing
tablet containing
tablet
floatable
derivatives
Prior art date
Application number
AT02702462T
Other languages
English (en)
Inventor
Frederique Bordes
Sylvie Cuart
Laurent Terrassin
Original Assignee
Ellipse Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0101711A external-priority patent/FR2820318B1/fr
Application filed by Ellipse Pharmaceuticals filed Critical Ellipse Pharmaceuticals
Application granted granted Critical
Publication of ATE326217T1 publication Critical patent/ATE326217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02702462T 2001-02-08 2002-02-07 Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin ATE326217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0101711A FR2820318B1 (fr) 2001-02-08 2001-02-08 Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR0116705A FR2820319B3 (fr) 2001-02-08 2001-12-21 Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu

Publications (1)

Publication Number Publication Date
ATE326217T1 true ATE326217T1 (de) 2006-06-15

Family

ID=26212870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02702462T ATE326217T1 (de) 2001-02-08 2002-02-07 Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin

Country Status (8)

Country Link
US (1) US20040115259A1 (de)
EP (1) EP1368002B1 (de)
AT (1) ATE326217T1 (de)
AU (1) AU2002235990A1 (de)
CA (1) CA2437630A1 (de)
DE (1) DE60211486D1 (de)
FR (1) FR2820319B3 (de)
WO (1) WO2002062321A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1253220C (zh) 2001-06-29 2006-04-26 贝克顿迪肯森公司 通过微管在真皮内输入疫苗和基因治疗剂
CN1720026A (zh) * 2002-10-22 2006-01-11 兰贝克赛实验室有限公司 含有阿夫唑嗪的缓释组合物
US7588774B2 (en) 2003-05-12 2009-09-15 Becton, Dickinson And Company Molecules enhancing dermal delivery of influenza vaccines
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine
US20060062845A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
US20060062846A1 (en) * 2004-09-17 2006-03-23 Cimex Pharma Ag Alfuzosin tablets and synthesis
ITMI20050391A1 (it) * 2005-03-11 2006-09-12 Ph & T S P A Formulazioni a rilascio controllato di alfuzosin
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation
US20080003286A1 (en) * 2006-06-29 2008-01-03 Sathya Narayana Vemula Sustained delivery alfuzosin compositions
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
WO2008073388A2 (en) * 2006-12-11 2008-06-19 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making and methods of use
WO2008102235A1 (en) * 2007-02-20 2008-08-28 Aurobindo Pharma Limited Controlled release formulations of alfuzosin
JP5773651B2 (ja) * 2007-12-21 2015-09-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 内部固形コア中に成長ホルモンを含有する固形脂質マイクロカプセル
CN114209668B (zh) * 2022-01-13 2023-01-31 山东新时代药业有限公司 一种盐酸阿夫唑嗪缓释制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
CN100335057C (zh) * 1996-08-29 2007-09-05 圣诺菲－安万特 阿夫唑嗪盐酸盐受控释放的片剂
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them

Also Published As

Publication number Publication date
EP1368002A2 (de) 2003-12-10
AU2002235990A1 (en) 2002-08-19
WO2002062321A3 (fr) 2003-02-27
FR2820319B3 (fr) 2003-12-05
WO2002062321A2 (fr) 2002-08-15
FR2820319A1 (fr) 2002-08-09
EP1368002B1 (de) 2006-05-17
US20040115259A1 (en) 2004-06-17
CA2437630A1 (fr) 2002-08-15
DE60211486D1 (de) 2006-06-22

Similar Documents

Publication Publication Date Title
ATE326217T1 (de) Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin
ATE324870T1 (de) Wirkstoffhaltige schwimmformen enthaltend polyvinylacetat und polyvinylpyrrolidon, deren verwendung und herstellung
NO20024947D0 (no) Effervesente granuler og fremgangsmåte for fremstilling av slike
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
FI963916L (fi) Uudet stabiloidut galeeniset formulaatiot, jotka sisältävät happolabiilia bentsimidatsoliyhdistettä, ja niiden valmistus
ATE303809T1 (de) Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
ES2174849T3 (es) Composiciones farmaceuticas con sabor agradable.
WO2001037785A3 (en) Novel methods and compositions involving opioids and antagonists thereof
CA2269807A1 (en) Substituted aminoalkanephosphonic acids
NO954320D0 (no) Lyosfærer omfattende gonadotropin
DE60024414D1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
DE69413393D1 (de) In 15-stellung substituierte 4-azasteroide
HK60192A (en) Drug particles having constant release
IS3789A7 (is) Aðferð við framleiðslu lyfjaskammta í föstu formimeð tempraðri losun virks þáttar
PL374827A1 (en) Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
ATE38836T1 (de) Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln.
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
EP0356035A3 (de) Arylalkylamine und -amide mit krampflösender und nervenschützender Wirkung
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
IL67686A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them
DE58909140D1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel.
DE69328976D1 (de) Antiallergisch triazolo (pyrrolo, thieno oder furano) azepinderivate
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties